Triple-Negative Breast Cancer

Foulkes et al. (Wed,) studied this question.

www.synapsesocial.com/papers/69d5719b75589c71d767e399 — DOI: https://doi.org/10.1056/nejmra1001389

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Gastrosplenic Fistula From Hodgkin's Lymphoma· 2009 · 736 citations
2. The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells· 2008 · 8,692 citations
3. MONOCLONAL MARKER THAT PREDICTS EARLY RECURRENCE OF BREAST CANCER· 1987 · 54 citations
4. Final Results of a Randomized Phase II Study Demonstrating Efficacy and Safety of BSI-201, a Poly (ADP-Ribose) Polymerase (PARP) Inhibitor, in Combination with Gemcitabine/Carboplatin (G/C) in Metastatic Triple Negative Breast Cancer (TNBC).· 2009 · 41 citations
5. Triple negative tumours: a critical review· 2007 · 899 citations